Skip to Main Content

Author Details

Ileana L Pi??a
Thomas Jefferson University
1980
386
80
PMIDPaper TitleJournal TitlePublished Year
37816446Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study.J Card Fail2024
36322269Investigating gender-based differential item functioning on the Kansas City Cardiomyopathy Questionnaire (KCCQ) using qualitative content analysis.Qual Life Res2023
37632309Importance of the 'area under the curve' from serial NT-proBNP measurements during treatment with sacubitril/valsartan.ESC Heart Fail2023
37558088Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.J Card Fail2023
37782695Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC).Circulation2023
37565973Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA Trial.JACC Heart Fail2023
37417824Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial.Circ Heart Fail2023
37344038Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.J Am Coll Cardiol2023
37115131Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan.JACC Heart Fail2023
37410011Prevalence and Incidence of Pre-HF Among Hispanics/Latinos.JACC Heart Fail2023
37042286Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure.J Am Heart Assoc2023
36974746Health status across major subgroups of patients with heart failure and preserved ejection fraction.Eur J Heart Fail2023
37401523Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartan.Eur J Heart Fail2023
37137386Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America.J Card Fail2023
37223933Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial.JAMA Cardiol2023
36802883Consistency Breeds Confidence: The Continuing Story of SGLT2 Inhibitors.Circulation2023
36599549Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan.JACC Heart Fail2023
36565199Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause.J Am Heart Assoc2023
36529605Participating in the Peer Review Process: The Journal of Cardiac Failure Construct.J Card Fail2023
36632934Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure.J Card Fail2023
36332897Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency.J Card Fail2023
34800079Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.Eur J Heart Fail2022
35616018Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.Circulation2022
35640729Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial.Am Heart J2022
35791065An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum.Eur J Heart Fail2022
35462033Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial.J Card Fail2022
35490873Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study.Prog Cardiovasc Dis2022
35688408Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction.J Card Fail2022
35618350Time to Re-Examine Maternity Leave in Cardiology Training: Proactive Rather Than Reactive.J Am Coll Cardiol2022
35446109Engaging Families in Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.J Am Heart Assoc2022
36545229Reflecting on the advancements of HFrEF therapies over the last two decades and predicting what is yet to come.Eur Heart J Suppl2022
36471037Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.Nat Med2022
36456072Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status.JACC Heart Fail2022
36562446CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.BMJ2022
36208161CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.Eur Heart J2022
36103292Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF Study.Clin Chem2022
35900838Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.Eur Heart J2022
36098051Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.Circulation2022
36229089Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.J Am Coll Cardiol2022
36378759Clinical and Socioeconomic Determinants of Angiotensin Receptor-Neprilysin Inhibitor Prescription at Hospital Discharge in Patients With Heart Failure With Reduced Ejection Fraction.Circ Heart Fail2022
36122820Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction.J Card Fail2022
36007991Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review.J Am Coll Cardiol2022
36050271CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research.Lancet Digit Health2022
36183276Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study.Circulation2022
35319725Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory.JAMA Cardiol2022
35044802Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.Circulation2022
35279929Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.Eur J Heart Fail2022
35301107Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry.J Card Fail2022
35083829Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.Eur J Heart Fail2022
35083485Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.Eur J Prev Cardiol2022
  • 1 - 50 of 386

Recommended Authors

Veraprapas Kittipibul
Duke University Medical Center, NC Duke Clinical Research Institute
Career Start Year 2017
Number of shared co-authors 4
Chayakrit Krittanawong
NYU Langone Health and NYU School of Medicine
Career Start Year 2016
Number of shared co-authors 7
Mohammad Al-Ani
University of Florida Gainesville
Career Start Year 2015
Number of shared co-authors 0
Husam M Salah
University of Arkansas for Medical Sciences
Career Start Year 2015
Number of shared co-authors 9
Meng Xu
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 4
Daniel A Steinhaus
University of Missouri-Kansas City, Saint Luke's Mid America Heart Institute
Career Start Year 2012
Number of shared co-authors 2
Nishant R Shah
Brown University Alpert Medical School
Career Start Year 2012
Number of shared co-authors 6
Auras R Atreya
AIG Hospitals Institute of Cardiac Sciences and Research
Career Start Year 2011
Number of shared co-authors 0
Aakriti Gupta
Yale/YNHH Center for Outcomes Research and Evaluation (CORE)
Career Start Year 2008
Number of shared co-authors 15
Hena Patel
University of Chicago Medical Center
Career Start Year 2008
Number of shared co-authors 4
Zachary L Cox
Department of Pharmacy Practice, Lipscomb University College of Pharmacy
Career Start Year 2007
Number of shared co-authors 11
Ayesha Hasan
The Ohio State University Wexner Medical Center
Career Start Year 2006
Number of shared co-authors 8
Sripal Bangalore
New York University Grossman School of Medicine
Career Start Year 2004
Number of shared co-authors 29
Ravi V Desai
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 4
Phillip D Levy
Wayne State University School of Medicine.
Career Start Year 2003
Number of shared co-authors 32
Zainab Samad
Aga Khan University, Pakistan Aga Khan University
Career Start Year 2001
Number of shared co-authors 15
Tamara B Horwich
university of california los angeles School of Medicine
Career Start Year 2001
Number of shared co-authors 15
Michelle M Graham
University of Alberta
Career Start Year 1999
Number of shared co-authors 7
Naveen L Pereira
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 8
Juan M Aranda
University of Florida
Career Start Year 1997
Number of shared co-authors 3
Lori B Daniels
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 20
R. Scott Wright
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 15
Rekha Garg
University of Florida
Career Start Year 1991
Number of shared co-authors 0
Stuart D Katz
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 17
Pamela S Douglas
Duke Clinical Research Institute, Duke University
Career Start Year 1984
Number of shared co-authors 50
Mary A Whooley
San Francisco Veterans Affairs Medical Center
Career Start Year 1983
Number of shared co-authors 14
Kent R Bailey
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 5
Ulf Dahlstr??m
Linkoping University
Career Start Year 1977
Number of shared co-authors 23
Christiane E Angermann
University and University Hospital Wurzburg
Career Start Year 1976
Number of shared co-authors 12
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 48

Collaborators

Gary Michael Felker
Duke University School of Medicine
Co-authored papers 47
William E Kraus
Duke Molecular Physiology Institute, Duke University School of Medicine
Co-authored papers 42
Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 25
John A Spertus
University of Missouri-Kansas City School of Medicine
Co-authored papers 25
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 24
Adrian F Hernandez
Duke University Medical Center
Co-authored papers 18
Frederick A Masoudi
University of Colorado School of Medicine
Co-authored papers 18
Mihai Gheorghiade
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 16
Paul A Heidenreich
Stanford University School of Medicine
Co-authored papers 13
Milton Packer
Co-authored papers 12
John S Rumsfeld
Stanford University
Co-authored papers 11
Carolyn S P Lam
Duke-NUS Medical School
Co-authored papers 11
Alan S Maisel
University of California
Co-authored papers 11
Robert O Bonow
Northwestern University Feinberg School of Medicine
Co-authored papers 11
Phillip J Schulte
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 10
Eric D Peterson
University of Texas Southwestern Medical Center
Co-authored papers 10
JoAnn Lindenfeld
Vanderbilt University Medical Center
Co-authored papers 10
Kevin J Anstrom
University of North Carolina at Chapel Hill
Co-authored papers 9
Barry M Massie
University of California at San Francisco
Co-authored papers 9
John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 9
Adam D DeVore
Duke University School of Medicine, NC Duke Clinical Research Institute
Co-authored papers 9
Randal J Thomas
Mayo Clinic Rochester
Co-authored papers 8
Harlan M Krumholz
Yale School of Medicine
Co-authored papers 8
Martha J Radford
New York University School of Medicine
Co-authored papers 8
Mariell Jessup
University of Pennsylvania Perelman School of Medicine
Co-authored papers 8
Marjorie King
Helen Hayes Hospital, NY and Columbia University
Co-authored papers 8
Karen Lui
Rush University Medical Center
Co-authored papers 7
James A Blumenthal
Duke University Medical Center
Co-authored papers 7
Neil Oldridge
College of Health Sciences, University of Wisconsin-Milwaukee
Co-authored papers 7
Mikhail Kosiborod
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City
Co-authored papers 7
Release 1.2